Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Risk Factors for Venous Thromboembolism
2003 Standout
Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy.
1977
The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases
1977
Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)
1987
Perfusion Scan Findings Understate the Severity of Angiographic and Hemodynamic Compromise in Chronic Thromboembolic Pulmonary Hypertension
1988
Human Fibrinogen
1988
Prospects for Cardiovascular Research
2001 StandoutNobel
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial
1992
Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial
2009
Irregular coronary lesion morphology after thrombolysis predicts early clinical instability
1991
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Physician practices in the management of venous thromboembolism: A community-wide survey
1992
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Improving enzymes by using them in organic solvents
2001 StandoutNature
Antithrombotic Therapy for VTE Disease
2012 Standout
The pathogenesis of atherosclerosis: An overview
1991
Thrombolytic therapy for pulmonary embolism
2009
Factors affecting .gamma.-chain multimer formation in crosslinked fibrin
1992
Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
1988
Nonlinear elasticity in biological gels
2005 StandoutNature
Involvement of the cooh-terminal portion of the alpha-chain of fibrin in the branching of fibers to form a clot
1987
Atherosclerosis — An Inflammatory Disease
1999 Standout
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
1990
Coronary lesion morphology in acute myocardial infarction: Demonstration of early remodeling after streptokinase treatment
1990
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia
1994
Pulmonary embolectomy: A 20-year experience at one center
1991
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Short- and long-term results after thrombolytic treatment of deep venous thrombosis
2000
Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
1987
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Molecular cardiology: New avenues for the diagnosis and treatment of cardiovascular disease
1989
Comparative Efficacy of a Two-Hour Regimen of Streptokinase Versus Alteplase in Acute Massive Pulmonary Embolism: Immediate Clinical and Hemodynamic Outcome and One-Year Follow-Up 11This study was partly supported by grants from Programme Hospitalier de la Recherche Clinique (Ministère de la Santé Publique), Paris; Boehringer Ingelheim, Reims Cedex, France; and Hoechst France, Puteaux, France.
1998
Electrophoretic Studies of Lysine-extracted Plasminogen
1965
The relationship between the lysine and the p-aminobenzamidine binding sites on human plasminogen
1975
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Biochemistry of Nitric Oxide and Its Redox-Activated Forms
1992 StandoutScience
A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
1986
A recombinant pro-urokinase derived mutant missing the growth factor-like domain does not bind to its receptor
1990
PROTEIN BINDING OF PANCREATIC PROTEOLYTIC ENZYMES*
1962
Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals.
1990 StandoutNobel
The Proteins Of The Exocrine Pancreas
1962
The purification and properties of human plasminogen
1964
The Effect of Plasmin on the Subunit Structure of Human Fibrin
1973
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
1990
Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasmin
1985
FIBRINOGEN AND FIBRIN
1984
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin
1981
Thrombolytic therapy in patients with acute myocardial infarction.
1985
Liver Transplantation in Man--II, a Report of two Orthotopic Liver Transplants in Adult Recipients
1968
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 Standout
The relationship between coronary artery lesions and myocardial infarcts: Ulceration of atherosclerotic plaques precipitating coronary thrombosis
1977
Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
1978
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
1987 Standout
Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains.
1987 StandoutNobel
Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.
1986 StandoutNobel
Polypeptide with Broad Biological Activity: Isolation from Small Intestine
1970 StandoutScience
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards
1984
REDUCTION OF PRESSOR EFFECTS OF ANGIOTENSIN I IN MAN BY SYNTHETIC NONAPEPTIDE (B.P.P.9a OR SQ 20,881) WHICH INHIBITS CONVERTING ENZYME
1973 StandoutNobel
Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis
1977
The Renin–Angiotensin System: Inhibition of Converting Enzyme in Isolated Tissues
1970 StandoutNatureNobel
Thrombolysis for acute deep vein thrombosis
2016
Further Studies on the Purification and Characterization of Human Plasminogen and Plasmin
1965
Intravenous short-term infusion of streptokinase in acute myocardial infarction.
1983
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
ANTI‐INFLAMMATORY EFFECT OF TRYPSIN
1957
The Properties of Poly-dl-alanyl Trypsin and Poly-dl-alanyl Chymotrypsin
1962 StandoutNobel
Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis
1991
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
1988
The aggressive treatment of acute myocardial infarction.
1985
Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting Enzyme
1970 StandoutNatureNobel
Hydration of Proteins and Polypeptides
1974
Plasminogen: Purification from Human Plasma by Affinity Chromatography
1970 StandoutScience
FIBRIN ASSEMBLY*
1983
Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activator
1983
Activity of the Reduced Zymogen of Streptococcal Proteinase
1970 StandoutNobel
Rotational diffusion analysis of the conformational alterations produced in plasminogen by certain antifibrinolytic amino acids
1973
PROPERTIES OF GUINEA PIG 7S ANTIBODIES
1963 StandoutNobel
Some Properties of Angiotensin Converting Enzyme in the Lung in vivo
1970 StandoutNatureNobel
[20] Urinary and kidney cell plasminogen activator (urokinase)
1976
The binding of plasminogen to fibrin: Evidence for plasminogen-bridging
1982
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
1989
Angiographie morphology and the pathogenesis of unstable angina pectoris
1985
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
The Effect of Plasmin on the Subunit Structure of Human Fibrinogen
1972
Rapid Lysis of Coronary Artery Thrombi with Anisoylated Plasminogen: Streptokinase Activator Complex
1986
Selective enzyme purification by affinity chromatography.
1968 StandoutNobel
S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.
1992
Localization of Individual Lysine‐Binding Regions in Human Plasminogen and Investigations on Their Complex‐Forming Properties
1980
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.
1981
The degradation of cartilage matrix by an intracellular protease
1964
Characterization of an Extremely Large, Ligand-Induced Conformational Change in Plasminogen
1990 StandoutScienceNobel
Radioimmunoassay of ACTH in plasma
1968 StandoutNobel
The pathogenesis of cancer metastasis
1980 StandoutNature
The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom
1962
Investigation of serum trypsin and related substances
1962
Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
1983
Ligand-induced Resistance of Staphylococcal Nuclease and Nuclease-T to Proteolysis by Subtilisin, α-Chymotrypsin, and Thermolysin
1969 StandoutNobel
Metabolism of the Angiotensins in Isolated Perfused Tissues
1969 StandoutNatureNobel
Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia
1982 StandoutNobel
Controlled study of thrombolytic therapy in deep vein thrombosis.
1973
Induction of Immunological Tolerance by Porcine Liver Allografts
1969 StandoutNature
DISULFIDE INTERCHANGE AND THE THREE-DIMENSIONAL STRUCTURE OF PROTEINS
1965 StandoutNobel
Early events in the plasmin digestion of fibrinogen and fibrin. Effects of plasmin on fibrin polymerization.
1977
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
Intravenous urokinase in acute myocardial infarction
1985
Molecular mechanism of physiological fibrinolysis
1978 Nature
A MODIFIED SPECTROPHOTOMETRIC DETERMINATION OF CHYMOTRYPSIN, TRYPSIN, AND THROMBIN
1959 Standout
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
1985
Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis
1984
NMR Assignment and Secondary Structure Determination of an Octameric 110 kDa Protein Using TROSY in Triple Resonance Experiments
2000 StandoutNobel
Fibrinolysis in Familial Pulmonary Hypertension
1979
Improved Procedure for the Isolation of Human Plasminogen
1961
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes
1969
Hormonal Control of Neutrophil Lysosomal Enzyme Release: Effect of Epinephrine on Adenosine 3′,5′-Monophosphate
1974 StandoutScienceNobel
Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung
1968 Nature
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline
2010
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.
1981
Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen
1987
Tumors: Wounds That Do Not Heal
1986 Standout
Proteolytic Enzymes, Cell Surface Changes, and Viral Transformation
1976
Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATION
1983
Clinicopathologic correlates of acute ischemic heart disease syndromes
1981
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
1991
Human fibrinopeptides isolation, characterization and structure
1966
Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.
1992
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
1985
A pilot study of urokinase therapy in cerebral infarction.
1976
Physician practices in the management of venous thromboembolism: A community-wide survey
1992
Serum-Induced Thrombosis
1959
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Axillary and Subclavian Venous Thrombosis
1991
Relationships of Ca++ to “Protein-bound” Phosphate Fractions of Mitochondria
1965 StandoutNobel
THE DESTRUCTION OF GLUCAGON, ADRENOCORTICOTROPIN AND SOMATOTROPIN BY HUMAN BLOOD PLASMA*
1959
Prevention of Pulmonary Emboli in a Respiratory Intensive Care Unit
1981
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
1985 Standout
Works of Sol Sherry being referenced
Thrombosis and urokinase
1977
Thrombolytic Therapy: Current Status
1988
Thrombolytic Therapy: Current Status
1988
The Urokinase-Pulmonary Embolism Trial
1969
Physicochemical Studies on Human Plasminogen (Profibrinolysin) and Plasmin (Fibrinolysin)
1958
The Urokinase-Streptokinase Pulmonary Embolism Trial (Phase II) Results
1974
Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development Conference
1980
The Clearance of Heterologous Protein from the Circulation of Normal and Immunized Man12
1958
The Activation of Human Plasminogen
1958
Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*
1964
The Activation of Human Plasminogen
1958
Coronary thrombosis in myocardial infarction
1974
THE ACTION OF THROMBIN ON SYNTHETIC SUBSTRATES
1954
Detection of serum fibrinogen and fibrin degradation products
1971
The Preparation and Properties of Human Fibrinogen of Relatively High Solubility*
1966
Human Fibrinogen of Relatively High Solubility. Comparative Biophysical, Biochemical, and Biological Studies with Fibrinogen of Lower Solubility*
1967
Treatment of Pulmonary Embolism with Urokinase Results of Clinical Trial (Phase 1)
1970
Coronary Thrombolysis for Evolving Myocardial Infarction
1984
High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulation
1986
The Enzymatic Dissolution Of Experimental Arterial Thrombi in the Dog by Trypsin, Chymotrypsin and Plasminogen Activators12
1954
Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase
1968
THE ACTION OF PLASMIN ON SYNTHETIC SUBSTRATES
1954
The Phase II Urokinase-Streptokinase Pulmonary Embolism Trial
1975
THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*
1959
BIOCHEMICAL, EXPERIMENTAL, AND CLINICAL STUDIES OF PROTEOLYTIC ENZYMES: WITH PARTICULAR REFERENCE TO THE FIBRINOLYTIC ENZYME OF HUMAN PLASMA
1957
Partial Purification and Properties of the Plasminogen Activator from Pig Heart*
1964
Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction
1986
High-dose, brief intravenous streptokinase early in acute myocardial infarction
1982
STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*
1959
Enzymic lysis of plasma clots: The influence of fibrin stabilization on lysis rates
1967
Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studies
1984
THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*
1959
THE FIBRINOLYTIC ACTIVITY OF STREPTOKINASE ACTIVATED HUMAN PLASMIN 1
1954
Fibrinolysis and Fibrinolytic Activity in Man
1959
Inhibition of fibrin polymerization by fibrinogen proteolysis products
1962
Prospects in antithrombotic therapy
1972
THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. II. CLINICAL OBSERVATIONS ON PATIENTS WITH MYOCARDIAL INFARCTION AND OTHER THROMBOEMBOLIC DISORDERS*†
1959
PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*
1962
Preventing pulmonary embolism with heparin in low doses
1976
The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally.
1966
ε-Aminocaproic Acid: an Inhibitor of Plasminogen Activation
1959
Isolation and characterization of the clottable low-molecular-weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4
1969
A Comparison of the Fibrinolytic and Fibrinogenolytic Effects of Plasminogen Activators and Proteolytic Enzymes in Plasma
1961